Gazette

Vol. 6 Sunday, 16 February 2025
Vol. 6 16 Feb 2025

Tuberculosis (TB) remains a major global health threat, killing about 1.2 million people each year despite existing vaccines and antibiotics. New vaccines and antibiotics are urgently needed to combat rising drug resistance and improve treatment effectiveness. Researchers are hopeful about recent innovations and repurposed drugs that could lead to breakthroughs in controlling TB.

3 highlights

TB remains the deadliest infectious disease on Earth, killing about 1.2 million people every year.

ice crystals expand and shatter bacterial membranes, killing the microbes. To protect against this, Calmette and Guérin added a small amount of glycerin, a cryoprotectant, to slow ice crystal formation. Their mycobacteria cultures grew well in the amalgam and could be frozen and thawed time and time again. Finally, the team added ox bile, rich in fat-dissolving enzymes and bile salts, to disperse clumps of bacteria.

even in the face of the growing threat of drug resistance, research has moved away from antibiotic discovery efforts to explore more profitable medicines. Developing and launching a new antibiotic costs $1.5 billion U.S. dollars, whereas cancer therapies require only $640 million to make overall. Antibiotics also rake in less revenue, approximately $46 million per year, as compared to cancer treatments ($1.7 billion per year), leaving big pharma with little incentive to focus on this forgotten pandemic.